265 related articles for article (PubMed ID: 12503076)
21. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
[TBL] [Abstract][Full Text] [Related]
22. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
23. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
24. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
Nagasaka T; Sharp GB; Notohara K; Kambara T; Sasamoto H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2003 Nov; 9(14):5306-12. PubMed ID: 14614014
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
27. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T
Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440
[TBL] [Abstract][Full Text] [Related]
28. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
Brabender J; Usadel H; Metzger R; Schneider PM; Park J; Salonga D; Tsao-Wei DD; Groshen S; Lord RV; Takebe N; Schneider S; Hölscher AH; Danenberg KD; Danenberg PV
Clin Cancer Res; 2003 Jan; 9(1):223-7. PubMed ID: 12538473
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
[TBL] [Abstract][Full Text] [Related]
30. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
31. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
[TBL] [Abstract][Full Text] [Related]
32. Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
Kim SH; Bae SI; Lee HS; Kim WH
Mol Carcinog; 2003 May; 37(1):32-8. PubMed ID: 12720298
[TBL] [Abstract][Full Text] [Related]
33. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
Jesien-Lewandowicz E; Jesionek-Kupnicka D; Zawlik I; Szybka M; Kulczycka-Wojdala D; Rieske P; Sieruta M; Jaskolski D; Och W; Skowronski W; Sikorska B; Potemski P; Papierz W; Liberski PP; Kordek R
Cancer Genet Cytogenet; 2009 Jan; 188(2):77-82. PubMed ID: 19100509
[TBL] [Abstract][Full Text] [Related]
34. O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.
Halford S; Rowan A; Sawyer E; Talbot I; Tomlinson I
Gut; 2005 Jun; 54(6):797-802. PubMed ID: 15888787
[TBL] [Abstract][Full Text] [Related]
35. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents.
Grombacher T; Eichhorn U; Kaina B
Oncogene; 1998 Aug; 17(7):845-51. PubMed ID: 9780001
[TBL] [Abstract][Full Text] [Related]
36. O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells.
Blough MD; Zlatescu MC; Cairncross JG
Cancer Res; 2007 Jan; 67(2):580-4. PubMed ID: 17234766
[TBL] [Abstract][Full Text] [Related]
37. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene.
Nakamura M; Watanabe T; Yonekawa Y; Kleihues P; Ohgaki H
Carcinogenesis; 2001 Oct; 22(10):1715-9. PubMed ID: 11577014
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma.
Furonaka O; Takeshima Y; Awaya H; Kushitani K; Kohno N; Inai K
Pathol Int; 2005 Jun; 55(6):303-9. PubMed ID: 15943786
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]